Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2007
11/15/2007WO2007129284A1 System and methods for actuation on magnetoresistive sensors
11/15/2007WO2007129278A1 A controllable magnetic system for biosensors
11/15/2007WO2007129277A2 A magnetic system
11/15/2007WO2007129114A2 Aptamers directed to recombinant muc1
11/15/2007WO2007129064A1 A chemical sensing device
11/15/2007WO2007129055A1 Tagging system
11/15/2007WO2007129053A1 Methods of diagnosis and treatment of equine laminitis and cushing' s syndrome
11/15/2007WO2007128987A2 Therapy targeting cathepsin s
11/15/2007WO2007128980A1 A protease detection product
11/15/2007WO2007128976A1 Lipovrotein senso
11/15/2007WO2007128942A1 Method for detecting localized defects present in a mineral fiber mat
11/15/2007WO2007128916A1 Detection of venous thromboembolic diseases by measurement of d-dimers and soluble fibrin levels
11/15/2007WO2007128884A1 Novel genes and markers in type 2 diabetes and obesity
11/15/2007WO2007128882A1 Information management techniques for metabolism-related data
11/15/2007WO2007128874A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
11/15/2007WO2007128873A1 A method for the preparation of maleimido derivatives of biomolecule labeling reactants and conjugates derived thereof
11/15/2007WO2007128851A1 Method for diagnosing and monitoring the effectiveness of dry-eye treatment
11/15/2007WO2007128806A2 Methods for the in vitro screening of compounds inhibiting production of infectious hiv-1 virions
11/15/2007WO2007128758A1 Diagnostic test unit
11/15/2007WO2007128737A2 Method and device to fractionate stem cells
11/15/2007WO2007128684A1 Method to detect states of anemia present in a blood sample
11/15/2007WO2007128570A2 In vitro method for the identification and early identification and for the concomitant monitoring of the therapy of drug- and addictive substance-induced liver damage
11/15/2007WO2007128550A1 Biocompatible three dimensional matrix for the immobilization of biological substances
11/15/2007WO2007128549A1 Method for quantifying a cell population of interest contained in a human blood sample
11/15/2007WO2007128450A1 Identification of prion proteins in milk
11/15/2007WO2007128429A1 Biomarkers for endometrial proliferation
11/15/2007WO2007128373A1 Procedure for the functional annotation of molecular networks
11/15/2007WO2007128344A1 Design and synthesis of biotinylated probes for n-acyl-ethanolamines
11/15/2007WO2007128286A1 Method for the coupled enzyme immunochemical assay of analytes by means of endogenous calibrators
11/15/2007WO2007128274A2 Improved process for qualitative and/or quantitative determination of small concentrations of organic trace substances in aqueous systems and an analysis apparatus for performing this process
11/15/2007WO2007128244A1 Method, oligonucleotide probe and test kit of predicting risk of negative pregnancy outcomes, and use thereof
11/15/2007WO2007128230A1 Method and system for screening the receptor-ligand binding in live cell
11/15/2007WO2007128136A1 A novel pilin glycoprotein from a group 4 pseudomonas aeruginosa strain
11/15/2007WO2007128133A1 Hair sequestered tracer for prosthesis leak detection
11/15/2007WO2007128132A1 Dissolved protein arthritis markers
11/15/2007WO2007128122A1 Method and system for monitoring growth characteristics
11/15/2007WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007WO2007128109A1 Aptamers that recognize the carbohydrate n-acetylgalactosamine (galnac)
11/15/2007WO2007128080A1 An assay for modulators of apoptosis
11/15/2007WO2007112332A3 Microfluidic chamber assembly for mastitis assay
11/15/2007WO2007110358A3 Means and method for predicting diabetes
11/15/2007WO2007110357A3 Means and method for diagnosing diabetes
11/15/2007WO2007107714A3 Clinical correlates
11/15/2007WO2007105081A3 Method for the measure of molecular interactions by measurement of the light reflected by planar surfaces
11/15/2007WO2007104763A9 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2
11/15/2007WO2007103788A3 Yeast reporter system based on fusion proteins of sup35p
11/15/2007WO2007095279A3 Dual nanoparticle assay for detection and separation of biological species
11/15/2007WO2007095045A3 Electronic detection immunoassays that utilize a binder support medium
11/15/2007WO2007092579A3 Compositions and methods for capturing and analyzing cross-linked biomolecules
11/15/2007WO2007092353A3 Pregnancy biomarker profiles, methods and compositions related thereto
11/15/2007WO2007089906A3 Cationic steroid antimicrobial compositions for treating or preventing herpes infections
11/15/2007WO2007089591A3 Compositions and methods for high throughput screening of pharmacological chaperones
11/15/2007WO2007084002A3 Antibiotics and methods for producing them.
11/15/2007WO2007080593A3 Siva ubiquitination and/or degradation-related activity and modulators thereof
11/15/2007WO2007079445A3 Aurora expression constructs
11/15/2007WO2007074449A3 Substantially invisible three-dimensional structure for the study of cells
11/15/2007WO2007071347A3 Selective marking of immunoglobulin glycans
11/15/2007WO2007063316A3 Method for identifying a modulator of a cell signalling
11/15/2007WO2007050798A3 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer
11/15/2007WO2007049157A3 Ovulation cycle monitoring and management
11/15/2007WO2007046095A3 Methods for testing the integrity of membranes and optically or electrochemically detectable nanoprobes thereof
11/15/2007WO2007044989A3 Modulators of nod1 signaling
11/15/2007WO2007044091A3 Analysis using microfluidic partitioning devices
11/15/2007WO2007030531A3 Reagents for testing and molecular imaging of liver cancer
11/15/2007WO2007022485A3 Sterilization of biosensors
11/15/2007WO2007020632A3 Methods and compositions for determining a level of biologically active serum paraoxonase
11/15/2007WO2007018556A3 Method for detection and decontamination of antigens by nanoparticle-raman spectroscopy
11/15/2007WO2007001422A3 High affinity antibodies against hmgb1 and methods of use thereof
11/15/2007WO2007001324A3 Methods and materials for determining pain sensitivity and predicting and treating related disorders
11/15/2007WO2006138275A3 Compositions and methods for treating and diagnosing cancer
11/15/2007WO2006128085A3 Cadherin-11-mediated modulation of hair growth
11/15/2007WO2006113289A3 Saposin d and fam3c are biomarkers for alzheimer's disease
11/15/2007WO2006082336A9 Device for bioassays with integrated detector
11/15/2007WO2006075245A3 Systems, methods, and compositions for detection of human papilloma virus in biological samples
11/15/2007WO2006060171A3 Methods and compositions related to phage-nanoparticle assemblies
11/15/2007WO2006031377A3 A system and method related to enhancing an immune system
11/15/2007WO2006018643A3 Electrochemical sensors
11/15/2007WO2006014464A3 Method for quantitative pcr data analysis system (qdas)
11/15/2007WO2005118878A3 Methods of screening for cell proliferation or neoplastic disorders
11/15/2007WO2005100601A3 L-sign polymorphisms and methods involving use of same
11/15/2007WO2005069906A3 Methods and compositions relating to vascular endothelial growth factor and th2 mediated inflammatory diseases
11/15/2007WO2005059509A3 Biosensors for detecting macromolecules and other analytes
11/15/2007WO2005040351A3 Compositions for inducing cell growth and differentiation and methods of using same
11/15/2007WO2005031303A3 Soluble phospholipids for use in clotting factor assays
11/15/2007WO2005029218A3 Method for studying cellular chronomics and casual relationships of genes using fractal genomics modeling
11/15/2007WO2005023186A3 Methods of identifying agents that inhibit the growth of cancer cells
11/15/2007WO2005021709A3 Cln101 antibodies
11/15/2007WO2004063715A3 Methods of using crystal structure of carboxyltransferase domain of acetyl-coa carboxylase, modulators thereof, and computer methods
11/15/2007WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007WO2004016752A3 Proteome-wide mapping of post-translational modifications using endonucleases
11/15/2007WO2003000840A3 Nitrilases
11/15/2007WO2002051306A3 Device for the determination of the concentration of nitrogen monoxide
11/15/2007US20070265897 System and Method of Creating, Aggregating, and Transferring Environmental Emission Reductions
11/15/2007US20070265514 Systems and methods for calibrating minimally invasive and non-invasive physiological sensor devices
11/15/2007US20070265509 Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry
11/15/2007US20070265436 Nucleotide sequences coding tumor-associated antigenic target polypeptide specific immunoglobulins for use in detection and prevention of cell proliferative disorders
11/15/2007US20070265433 Process and Materials for the Rapid Detection of Streptococcus Pneumoniae Employing Purified Antigen-Specific Antibodies
11/15/2007US20070265430 Made by inter-molecularly crosslinking the fluorescent protein such as a phycobiliprotein with itself; easier to purify; assay sensitivity; use in labeling and detection of biomolecules; crosslinker such as disuccinimidyl suberate
11/15/2007US20070265350 Method of identifying compounds useful to treat neuronal degenerative diseases
11/15/2007US20070265341 Compositions and methods for treating eye disorders and conditions